Skip to main content

Table 2 Diagnostic phase indicators

From: Multicentre clinical radiotherapy audit in rectal cancer: results of the IROCA project

INDICATORS ICO-B ICO-G ICO H IPO NO WCO All  
N
(%)
N
(%)
N
(%)
N
(%)
N
(%)
N
(%)
N % P
Diagnosed at a different hospital 23
(57.5)
33
(82.5)
37
(92.5)
38
(97.4)
12
(54.5)
37
(92.5)
180 81.4 0.000
Pre-treatment MRI 34
(85.0)
40
(100)
40
(100)
24
(61.5)
18
(81.8)
37
(92.5)
193 87.3 0.000
Pre-treatment pelvic US 16
(40.0)
3
(7.5)
17
(42.5)
17
(43.6)
5
(22.7)
3
(7.5)
61 27.6 0.000
Pre-treatment thoracoabdominal CT 40
(100)
40
(100)
39
(97.5)
37
(94.9)
19
(86.4)
6
(15.0)
181 81.9 0.000
TNM staging 40
(100)
39
(97.5)
40
(100)
35
(89.7)
22
(100)
39
(97.5)
215 97.3 0.046
MRI staging 36
(90)
34
(85.0)
36
(90)
4
(10.3)
0
(0.0)
38
(95.0)
148 67.0 0.000
Presented to MTB 25
(62.5)
20
(50.0)
34
(85.0)
39
(100)
11
(50.0)
38
(95.0)
167 75.6 0.000
Presented at pre-treatment RO clinical session 40
(100)
40
(100)
39
(97.5)
0
(0.0)
22
(100)
0
(0.0)
141 63.8 0.000
Time between biopsy and first visit at RO (±4) [days] 32.6 30.5 39.2 58.6 45.9 21.6 210 37.6 < 0.001
Time between first visit at RO and beginning of RT [days] 15.1 16.5 19.7 16.0 28.5 38.8 221 22.0 < 0.001